2 months ago
China’s first BCMA CAR-T therapy successfully treats an overseas patient with advanced relapsed myeloma. 🎉🎉To assess whether the condition is suitable for CAR-T or clinic therapy, you can su...
2 months ago
Yescarta 2L DLBCL Diffuse large B-cell lymphoma (DLBCL) is one of the most common and aggressive types of non-Hodgkin’s lymphoma, affecting thousands of adults worldwide each year. Despite ad...
2 months ago
Tisagenlecleucel Mechanism of Action Introduction: Revolutionizing Cancer Treatment with CAR-T Cell Therapy Tisagenlecleucel, a groundbreaking chimeric antigen receptor (CAR) T cell immunotherapy, ...
2 months ago
**China’s CAR-T Therapy Approved for New Indication: Bringing New Hope to Relapsed Mantle Cell Lymphoma Patients** MCL The approval of Relmacabtagene Autoleucel brings renewed hope for ...
2 months ago
China’s Fully Human BCMA CAR-T Therapy: Bringing New Hope for High-Risk Relapsed/Refractory Multiple Myeloma Mutiple Myeloma Multiple Myeloma (MM) is a complex and aggressive cancer origi...
2 months ago
Multiple Myeloma Solution ** Breakthroughs and Hope in Blood Cancer Treatment** Mutiple Myeloma #MultipleMyeloma #BloodCancer #CART #HopeForPatients #CARTcelltherapy #Immunotherapy Multiple myelo...
2 months ago
Tisagenlecleucel Indications: A Comprehensive Overview Tisagenlecleucel, marketed as Kymriah, represents a groundbreaking advancement in CAR-T cell therapy. This innovative treatment harnesses the ...
2 months ago
Tisagenlecleucel Follicular Lymphoma Tisagenlecleucel, a groundbreaking CAR-T cell therapy, has shown remarkable potential in the treatment of relapsed or refractory follicular lymphoma (r/r FL). T...
2 months ago
**Иностранные пациенты ищут лечение: Лучшая терапия CAR-T в Китае! Первый российский пациент с множественной миеломой успешно очистил опухоль и достиг CR!** В течение пяти лет после постано...
2 months ago
**Seeking Medical Treatment Abroad: The Best CAR-T Therapy is in China! The First Russian Multiple Myeloma Patient Successfully Achieves Complete Tumor Clearance and CR!** patient story Over the f...
2 months ago
Tisagenlecleucel FDA Approval Tisagenlecleucel, commercially known as Kymriah, is a groundbreaking CAR-T cell therapy that has revolutionized the treatment landscape for certain types of blood canc...
2 months ago
Tisagenlecleucel DLBCL Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin’s lymphoma that affects thousands of people worldwide each year. While traditional treatments ...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
